Targeting errant immune system enzyme kills myelodysplastic cells Scientists have successfully targeted a malfunctioning immune system enzyme to kill diseased cells from patients with myelodysplastic syndrome -- a blood disorder and precursor to leukemia. Researchers say their successful laboratory tests in human MDS cells and mouse models of MDS provide a molecular target for designing new drugs to battle a syndrome with few effective treatments.
July 8, 2013 - Science Daily
Already virtually bonded, A's visit LeGrande A's relievers Ryan Cook, Jerry Blevins and Sean Doolittle paid a visit to 14-year-old Nick LeGrande, who has severe aplastic anemia, a rare life-threatening blood disorder that affects six out of every one million people.
July 8, 2013 - Major League Baseball